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urvival signals elicited by cytokines include the acti-
 
vation of phosphatidylinositol 3-kinase (PI3K), which
in turn promotes the activation of protein kinase B
(PKB). Recently, PKB has been demonstrated to phosphorylate
and inactivate forkhead transcription factor FKHR-L1, a
potent inducer of apoptosis. To explore the mechanisms
underlying the induction of apoptosis after cytokine
withdrawal or FKHR-L1 activation, we used a cell line in
which FKHR-L1 activity could be specifically induced.
Both cytokine withdrawal and FKHR-L1 activation induced
apoptosis, which was preceded by an upregulation in
 
p27
 
KIP1
 
 and a concomitant decrease in cells entering the
cell cycle. Induction of apoptosis by both cytokine withdrawal
and activation of FKHR-L1 correlated with the disruption of
mitochondrial membrane integrity and cytochrome c release.
S
 
This was preceded by upregulation of the pro-apoptotic
Bcl-2 family member Bim. Ectopic expression of an inhibitory
mutant of FKHR-L1 substantially reduced the levels of apop-
tosis observed after cytokine withdrawal. Activation of PKB
alone was sufficient to promote cell survival, as measured by
maintenance of mitochondrial integrity and the resultant
inhibition of effector caspases. Furthermore, hematopoietic
 
stem cells isolated from Bim
 

 
/
 

 
 mice exhibited reduced
levels of apoptosis upon inhibition of PI3K/PKB signaling.
These data demonstrate that activation of FKHR-L1 alone
can recapitulate all known elements of the apoptotic program
normally induced by cytokine withdrawal. Thus PI3K/PKB–
mediated inhibition of this transcription factor likely provides
an important mechanism by which survival factors act to
prevent programmed cell death.
 
Introduction
 
In the absence of cytokines, hematopoietic cells stop prolif-
erating and undergo programmed cell death, a process also
known as apoptosis. This dependence on cytokines is necessary
to maintain homeostasis in the immune system, and dys-
regulation of this process has been associated with autoim-
mune diseases, as well as malignancies (for review see
Rinkenberger and Korsmeyer, 1997). The activation of cysteine
proteases (caspases), which leads to the cleavage of various
substrates, including poly(ADP-ribose) polymerase (PARP),*
and degradation of chromosomal DNA, characterizes a cru-
cial step in the induction of apoptosis (Cryns and Yuan,
1998). Caspases exist as inactive pro-enzymes in the cell that
are activated through proteolytic cleavage upon induction of
the apoptotic program (for review see Budihardjo et al., 1999).
A well-characterized mechanism of initiating apoptosis is
 
through ligand-mediated activation of cell surface death
receptors, such as the tumor necrosis factor receptors and
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CD95 (APO-1/Fas) (for review see Nagata, 1999). Cas-
pase-8 is indispensable for transducing apoptotic signals ini-
tiated by death receptors, as demonstrated by the observa-
tion that CD95 signaling is abrogated in caspase-8
 

 
 mice
(Varfolomeev et al., 1998). Caspase activation can also be
triggered via a death receptor–independent mechanism, in-
volving the regulation of mitochondrial membrane perme-
ability. Central to this “intrinsic” means of mitochondrial-
initiated caspase activation is the release of cytochrome c
from the intermembrane space of mitochondria into the cy-
tosol. Cytochrome c, together with apoptosis activating fac-
tor 1 (Apaf-1), promotes activation of caspase-9 (Li et al.,
1997; Srinivasula et al., 1998), which then activates down-
stream caspases, such as caspase-3 and -7 (Budihardjo et al.,
1999). Although loss of mitochondrial integrity can also be
induced by death receptors, it is not essential for their induc-
tion of apoptosis (Strasser et al., 1995).
Indispensable for the regulation of mitochondrial integ-
rity are proteins of the Bcl-2 family. These consist of anti-
apoptotic members, such as Bcl-2, Mcl-1, and Bcl-XL and
pro-apoptotic members, such as Bad, Bim, and Bid (for re-
view see Adams and Cory, 1998). One mechanism by
which cytokines are believed to promote survival is by in-
hibiting transcription (Dijkers et al., 2000a; Shinjyo et al.,
2001) or activity (del Peso et al., 1997; Songyang et al.,
1997) of pro-apoptotic members, as well as transcription-
ally upregulating anti-apoptotic members (Chao et al.,
1998; Kuribara et al., 1999).
Protein kinase B (PKB), also known as c-akt, is regulated
by agonist-induced phosphatidylinositol 3-kinase (PI3K)
activation, and has been proposed to regulate cytokine-
mediated cell survival (Ahmed et al., 1997; Songyang et al.,
1997; Eves et al., 1998). Anti-apoptotic signals from PKB
include upregulation of Mcl-1 (Wang et al., 1999) and in-
hibitory phosphorylation of Bad (Songyang et al., 1997),
although the relevance of Bad phosphorylation for the sur-
vival of hematopoietic cells remains unclear (Scheid and
Duronio, 1998). A recently identified mechanism by
which PKB can promote rescue from apoptosis is through
inhibitory phosphorylation of the forkhead transcription
factor FKHR-L1 (FOXO3a) (Brunet et al., 1999; Dijkers
et al., 2000a). Activity of this transcription factor has been
linked to the induction of apoptosis in hematopoietic cells
(Brunet et al., 1999; Dijkers et al., 2000a,b). Although it
has been demonstrated in several systems that PKB can
mediate rescue from apoptosis, it is not clear whether PKB
exerts its anti-apoptotic effect upstream (Kennedy et al.,
1999) or downstream (Zhou et al., 2000) of mitochondria.
Furthermore, little is known concerning the mechanisms
by which activation of FKHR-L1 can lead to induction of
the apoptotic program.
Here, we investigate the mechanisms of cytokine with-
drawal– and forkhead-induced apoptosis and the role of
PKB in rescue from apoptosis in cytokine-deprived cells.
Our data demonstrate that FKHR-L1, as well as cytokine
withdrawal, induce apoptosis through a death receptor–
independent pathway. This involves transcriptional upregu-
lation of the pro-apoptotic Bcl-2 family member Bim, loss
of mitochondrial integrity, cytochrome c release, and caspase
activation. Thus, PKB can protect cells from cytokine with-
drawal–induced apoptosis by inhibiting FKHR-L1, result-
ing in the maintenance of mitochondrial integrity. These
data shed new light on the mechanisms by which cytokines,
through regulation of PI3K activity, can modulate the sur-
vival of hematopoietic lineages.
 
Results
 
Induction of apoptosis correlates with upregulation 
of p27
 
KIP1
 
 and Bim
 
Cytokines of the interleukin (IL)-3, IL-5, and granulocyte
macrophage colony–stimulating factor family have a well-
established function in transducing a proliferative and anti-
apoptotic response in hematopoietic target cells and their
precursors (de Groot et al., 1998; Guthridge et al., 1998;
Reddy et al., 2000). To examine the mechanisms underly-
ing cytokine withdrawal–induced apoptosis, we used the
mouse pre-B cell line, Ba/F3, which requires IL-3 both for
proliferation as well as to overcome the default apoptotic
program. Previously, ourselves and others have shown that
one mechanism by which cytokine-mediated rescue from
apoptosis may be achieved is through inhibitory phosphor-
ylation of the forkhead transcription factor FKHR-L1 by
PKB (Brunet et al., 1999; Dijkers et al., 2000a; Kashii et
al., 2000; Uddin et al., 2000). To specifically analyze the
effect of FKHR-L1 activity, we generated cell lines stably
overexpressing an inducible form of active FKHR-L1, in
which all three inhibitory phosphorylation sites were
mutated to alanine, FKHR-L1(A3):ER* (Dijkers et al.,
2000a). Addition of 4-hydroxy tamoxifen (4-OHT) to
these cells results in the rapid induction of FKHR-L1 tran-
scriptional activity, promoting the induction of bona fide
forkhead targets (Dijkers et al., 2000a,b). This occurs
within a similar time frame as FKHR-L1 dephosphoryla-
tion and activation after cytokine deprivation. Importantly
addition of 4-OHT to Ba/F3 cells not expressing FKHR-
L1(A3):ER* has no effect on apoptosis.
Cells were either cytokine-starved or treated with 4-OHT
for 24 h and apoptosis was measured by analyzing binding
of annexin V-FITC. Cells that are annexin V positive repre-
sent early apoptotic cells, whereas cells that are stained for
both annexin V and propidium iodide (PI) represent cells
that have initiated the apoptotic program for a longer period
of time. Cells that are dead through necrosis are PI positive
and annexin V negative. Both cytokine withdrawal and
FKHR-L1 activity induced apoptosis to a similar degree
(Fig. 1 A, top and middle; IL-3 withdrawal: 25% 
 

 
 4%;
4-OHT addition: 33% 
 

 
 4%). Next, we analyzed the kinet-
ics by which apoptosis was induced using DNA laddering, a
measure for the final events characterizing apoptosis. Both
cytokine withdrawal and FKHR-L1 activity induced apop-
tosis within a similar time frame (Fig. 1 A, bottom). Re-
cently, we have demonstrated that both p27
 
KIP1
 
 and Bim are
transcriptional targets of FKHR-L1 (Dijkers et al., 2000a,b).
We examined whether the kinetics of upregulation of
p27
 
KIP1
 
 and Bim protein correlated with induction of apop-
tosis. Both cytokine withdrawal and FKHR-L1 activation
resulted in an upregulation of p27
 
KIP1 
 
and Bim (Fig. 1, B
and C). These events occurred relatively early and preceded
the cleavage of DNA observed in Fig. 1 A.
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Cytokine withdrawal and FKHR-L1 activity induce 
apoptosis independently of death receptor activation
 
FKHR-L1 has been proposed to induce Fas ligand (FasL) in
T cells (Brunet et al., 1999), which could contribute to
FKHR-L1–mediated induction of apoptosis. Fas/FasL sig-
naling induces cleavage and activation of caspase-8, which is
an indispensable and specific downstream event of death re-
ceptor–induced apoptosis (Juo et al., 1998; Varfolomeev et
Figure 1. Induction of apoptosis by cytokine 
withdrawal or FKHR-L1 activity. (A, top) 
Ba/F3 cells were cultured in the presence 
or absence of cytokines. FKHR-L1(A3):ER* 
cells were cultured with IL-3 without or 
with 4-OHT (100 nM) for 24 h and analyzed 
for annexin V binding and PI staining as 
described in the Materials and methods. 
(Bottom) Ba/F3 cells were IL-3 starved (left) 
or FKHR-L1(A3):ER*–expressing cells were 
treated with 4-OHT (100 nM, right) for the 
times indicated. DNA laddering was analyzed 
as described in the Materials and methods. 
(B) Ba/F3 cells were cytokine-starved for the 
indicated times, lysed, and equal amounts 
of protein were analyzed for levels of 
p27KIP1 (top) or Bim (middle). Samples 
were analyzed with a RACK1 antibody to 
verify equal protein loading (bottom). (C) 
Ba/F3 cells stably expressing FKHR-L1(A3):
ER* were treated with 4-OHT for the times 
indicated, lysed, and analyzed as above. 
Data depicted are representative of at least 
three independent experiments.
Figure 2. Death receptor signaling is 
not activated in response to cytokine 
deprivation or FKHR-L1 activation. (A) 
Caspase-8 cleavage was analyzed in 
Ba/F3 cells that were cytokine starved 
for the times indicated. (B) Analysis of 
caspase-8 cleavage in 4-OHT–treated 
(100 nM) FKHR-L1(A3):ER* cells. (C) 
Jurkat cells were treated with or without 
FAS18 (1 g/ml). After 24 h, samples 
were harvested and protein concentration 
was measured. An equal amount of 
protein was analyzed by SDS-PAGE 
and anti–caspase-8 Western blotting. 
Data depicted are representative of at 
least three independent experiments. 
(D) Ba/F3 cells were electroporated with 
1 g renilla luciferase and either 20 g 
of a FasL promoter construct (FasL–LUC) 
or a construct containing three forkhead 
binding sites from the FasL promoter 
(FHRE-LUC). After culture for 18 h with 
or without IL-3, cells were lysed and 
analyzed for the amount of produced 
luciferase protein. Data represent the 
mean of three independent experi-
ments  SD. (E) Ba/F3 cells or Jurkat 
cells were treated for 24 h with SUPER-
Fas Ligand (50 ng/ml) and analyzed for 
annexin V binding and PI staining as de-
scribed in the Materials and methods.
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al., 1998). Analysis of caspase-8 cleavage is thus a means to
discriminate between death receptor–dependent and –inde-
pendent induction of apoptosis. As Ba/F3 cells express Fas,
albeit at very low levels (Marshall et al., 2000; Santos-Beneit
and Mollinedo, 2000), forkhead-mediated induction of
FasL could potentially trigger apoptosis by inducing cas-
pase-8 activation. We analyzed a potential role for Fas/FasL
signaling in the induction of apoptosis by cytokine with-
drawal or forkhead activation by measuring caspase-8 cleav-
age. Although Ba/F3 cells expressed caspase-8, neither cyto-
kine withdrawal (Fig. 2 A) nor forkhead activity (Fig. 2 B)
resulted in caspase-8 cleavage. As a positive control, Jurkat T
cells were treated with a cross-linking anti-Fas antibody,
which clearly induced cleavage and activation of caspase-8
(Fig. 2 C).
In addition, to examine the effect of cytokine withdrawal
on FasL induction, Ba/F3 cells were transiently transfected
with a FasL promoter reporter construct (Holtz-Heppel-
mann et al., 1998; Brunet et al., 1999). Cytokine with-
drawal had no effect on FasL promoter activity (Fig. 2 D).
In contrast, a reporter construct under the control of the
portion of the FasL promoter that contains three forkhead
binding sites (FHRE-LUC) was strongly induced upon cy-
tokine withdrawal. This suggests that although in an artifi-
cial context these FasL promoter forkhead binding sites can
be regulated, this is not the case in Ba/F3 cells in the context
of the intact FasL promoter itself. Furthermore, we were un-
able to detect an upregulation of FasL protein by Western
blotting (unpublished data). In accordance with these re-
sults, treatment of Ba/F3 cells for 24 h with recombinant,
species cross-reactive, active FasL had no effect on the per-
centage of apoptotic cells, whereas in Jurkat cells FasL at this
concentration strongly induced apoptosis (Fig. 2 E). Taken
together, these data demonstrate that Ba/F3 cells are not sus-
ceptible to FasL-mediated killing and argue against a role for
Fas/FasL signaling in FKHR-L1–mediated apoptosis.
 
Cytokine withdrawal and FKHR-L1 activity induce 
cell cycle arrest followed by apoptosis
 
p27
 
KIP1
 
 is involved in cell cycle arrest in G
 
1
 
 through the inhi-
bition of cyclin–CDK complexes (Polyak et al., 1994;
Toyoshima and Hunter, 1994), but has also been described
to function in the induction of apoptosis through a yet un-
identified mechanism (Wang et al., 1997; Dijkers et al.,
2000a). To see whether upregulation of p27
 
KIP1
 
 reflected an
altered distribution of cells in the cell cycle, we analyzed the
cell cycle profile of cells at various time points. Upon cyto-
kine withdrawal, cells stopped initiating cell division and ac-
cumulated in G
 
1
 
, within the first 8 h of starvation (Fig. 3 A).
After 16 h of cytokine deprivation cells started to undergo
apoptosis, as measured by cells having a DNA content 
 

 
2
 
n
 
chromosomes, the sub-G
 
1
 
 peak. By 48 h, a majority of cells
had initiated a program of apoptotis (58% 
 
 
 
5%). Similar
findings were observed in 4-OHT–treated FKHR-L1(A3):
ER* cells (Fig. 3 B; 48 h, 49% 
 

 
 3%), suggesting that the
presence of a G
 
1
 
 arrest before the onset apoptosis is probably
related to the initial upregulation of p27
 
KIP1
 
 (Fig. 1, B
and C).
 
Caspase activation and PARP cleavage follow 
cytokine withdrawal and FKHR-L1 activation
 
Very little is known regarding mechanisms by which cyto-
kine withdrawal promotes caspase activation and cleavage of
apoptotic substrates (Hieronymus et al., 2000; Khaled et al.,
2001), and the function of FKHR-L1 therein remains to be
established. We sought to investigate this in more detail, ex-
amining both cytokine withdrawal and FKHR-L1 activity.
Using antibodies specific for cleaved caspase-3 and -7, their
activation was analyzed after cytokine withdrawal. Caspase-3
(Fig. 4 A, top) and -7 (Fig. 4 A, middle) were both cleaved
after cytokine withdrawal. This occurred 
 

 
16 h after cyto-
kine removal. Analysis of 4-OHT–treated FKHR-L1(A3):
ER* cells also showed similar kinetics of caspase-3 and -7
cleavage (Fig. 4 B, top and middle). A well-characterized
caspase substrate that is cleaved when cells undergo apopto-
sis is PARP (Lazebnik et al., 1994), an enzyme involved in
DNA repair (for review see D’Amours et al., 1999). To ex-
amine whether PARP is also cleaved in either cytokine with-
drawal– or forkhead-induced apoptosis, lysates of cytokine-
starved cells or 4-OHT–treated FKHR-L1(A3):ER* cells
were again analyzed. Both IL-3 withdrawal (Fig. 4 C, left)
and forkhead activity (Fig. 4 C, right) resulted in PARP
Figure 3. Cell cycle analysis of cytokine-
starved cells and cells in which FKHR-L1 
activity is induced. (A) Ba/F3 cells were 
cytokine starved for the times indicated, 
fixed, stained with PI, and analyzed by 
FACS®. (B) Ba/F3 cells stably expressing 
FKHR-L1(A3):ER* were treated with 4-OHT 
(100 nM) for the times indicated and 
processed as in A. Data depicted are 
representative of at least three independent 
experiments.
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cleavage with kinetics similar to caspase activation (Fig. 4, A
and B). These data suggest that similar mechanisms are
involved in both cytokine withdrawal– and FKHR-L1–
induced apoptosis. Furthermore, upregulation of both
p27
 
KIP1 
 
and Bim precedes the activation of caspases (Fig. 1,
B and C). The kinetics of cell cycle arrest, caspase activation,
and cell death are remarkably similar between 4-OHT–
induced FKHR-L1 activation and IL-3 withdrawal. These
observations can be reconciled, as 4-OHT addition results in
FKHR-L1 activation within 30 min, and IL-3 withdrawal
results in FKHR-L1 dephosphorylation after 60 min (Dijk-
ers et al., 2000a,b).
 
Cytokine withdrawal and FKHR-L1 activity promote 
mitochondrial depolarization
 
Mitochondria can play a critical role in the initiation of
apoptosis, which is accompanied by a loss of mitochondrial
transmembrane potential and leakage of cytochrome c (Liu
et al., 1996). This, together with apoptosis activating factor
1 (Apaf-1), is required for activation of the “caspase cascade”
(Li et al., 1997; Srinivasula et al., 1998) and is indispensable
for death receptor–independent induction of apoptosis. To
analyze mitochondrial integrity in apoptotic Ba/F3 cells, we
used rhodamine-123 (Rh-123), a dye that binds to mito-
chondria in a membrane potential–dependent way (Ferlini
et al., 1996; Scaduto and Grotyohann, 1999). In cytokine-
starved Ba/F3 cells (Fig. 5 A), as well as in 4-OHT–treated
FKHR-L1(A3):ER* cells (Fig. 5 B), loss of 
 

 
m
 
 was observed
after 16 h, and mitochondrial transmembrane depolariza-
tion increased dramatically over time (48 h: IL-3 withdrawal
50% 
 

 
 5%; 4-OHT addition 49% 
 

 
 3%). The kinetics
were similar to those of caspase activation (Fig. 4, A and B).
This suggests that both cytokine withdrawal and FKHR-L1
activation result in a loss of mitochondrial transmembrane
potential, subsequently resulting in cytochrome c release and
activation of caspases.
 
Inhibition of PI3K or direct activation of FKHR-L1 
results in cytochrome c release from mitochondria
 
Next, we examined whether the loss of mitochondrial trans-
membrane potential coincided with cytochrome c release
into the cytosol. Therefore, Ba/F3 cells were deprived of cy-
tokines and release of cytochrome c was measured as de-
scribed in the Materials and methods. As shown in Fig. 6,
Ba/F3 cells cultured in the presence of IL-3 showed little cy-
tosolic cytochrome c, whereas cytokine withdrawal strongly
induced cytochrome c
 
 
 
release from the mitochondria. This
release appears to coincide with the mitochondrial mem-
Figure 4. Analysis of caspase activation 
and PARP cleavage in cytokine-starved 
cells and 4-OHT–treated FKHR-L1(A3):
ER* cells. (A) Cells were IL-3 starved for 
the times indicated and caspase-3 and -7 
activation was analyzed using cleavage-
specific antibodies. Equal protein loading 
was verified by analyzing samples for 
RACK1 expression. (B) 4-OHT–treated 
FKHR-L1(A3):ER* cells were analyzed as 
in A. (C) PARP cleavage was examined in 
cytokine-starved cells (left) or 4-OHT–
treated FKHR-L1(A3):ER* cells (right). 
Data depicted are representative of at 
least three independent experiments.
Figure 5. Induction of mitochondrial transmem-
brane depolarization by cytokine starvation or 
FKHR-L1 activity. (A) Ba/F3 cells were IL-3 starved 
for the times indicated and mitochondrial transmem-
brane depolarization was measured using Rh-123 
staining as described in the Materials and methods. 
(B) 4-OHT–treated FKHR-L1(A3):ER* cells were 
analyzed as in A. Data depicted are representative 
of at least three independent experiments.
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brane depolarization measured in Fig. 5. To investigate the
involvement of the PI3K/PKB pathway in cytochrome c re-
lease, Ba/F3 cells were treated with the PI3K inhibitor
LY294002. Again, in control cells, cytochrome c was lo-
calized in the mitochondria, whereas in the presence of
LY294002, cytochrome c was released into the cytosol. Sim-
ilarly, treatment with 4-OHT strongly induced cytochrome
c release into the cytosol in FKHR-L1(A3):ER* Ba/F3 cells.
These data demonstrate that inhibition of PI3K or activa-
tion of FKHR-L1 alone is sufficient to promote cytochrome
c release from the mitochondria into the cytosol.
 
PKB-mediated rescue from apoptosis correlates with 
maintenance of mitochondrial integrity
 
Although PKB has been shown to be involved in the inhibi-
tion of apoptosis by survival factors (Ahmed et al., 1997;
Songyang et al., 1997; Eves et al., 1998), a role for this ki-
nase in the regulation of mitochondrial integrity remains
unclear. PKB has been proposed to rescue cells from apopto-
sis by maintaining mitochondrial transmembrane potential
and preventing cytochrome c release (Kennedy et al., 1999).
However, others have observed rescue from apoptosis down-
stream of cytochrome c release (Zhou et al., 2000). To in-
vestigate the role of PKB in maintenance of mitochondrial
integrity in more detail, we made use of a polyclonal Ba/F3
cell line stably expressing a 4-OHT–inducible, active form
of PKB, myrPKB:ER* (Dijkers et al., 2000a). Treatment of
these cells with 4-OHT resulted in a dramatic phosphoryla-
tion of myrPKB:ER* (Fig. 7 A, top), allowing us to analyze
the effect of PKB activation after cytokine withdrawal. In-
deed, activation of PKB in the absence of cytokines was suf-
ficient to rescue cytokine-starved myrPKB:ER* cells from
apoptosis, as measured by annexin V-FITC staining (Fig. 7
B). To further elucidate a role for PKB upstream or down-
stream of mitochondria, we analyzed whether PKB was ca-
pable of abrogating cytokine withdrawal–induced loss of mi-
tochondrial transmembrane potential. For this purpose, Ba/
F3 and myrPKB:ER* cells were cultured with or without IL-3
in the presence or absence of 4-OHT. In Ba/F3 cells, loss of
mitochondrial transmembrane potential in the absence of
cytokines could not be rescued by 4-OHT (Fig. 7 C, top),
excluding aspecific effects of 4-OHT. In myrPKB:ER* cells,
however, addition of 4-OHT substantially decreased the loss
of 
 

 
m
 
 upon cytokine withdrawal (Fig. 7 C, bottom). Subse-
quently, caspase activity was analyzed. Activity of both cas-
pase-3 and -7 was substantially reduced in 4-OHT–treated
compared with untreated myrPKB:ER* cells. Our findings
of a partial rescue from apoptosis (Fig. 7 B) and caspase ac-
tivity (Fig. 7 D) may be explained by the fact that the myr-
PKB:ER* cell line is a polyclonal cell line, potentially ex-
pressing heterogeneous levels of myrPKB:ER*, the lower
levels being insufficient to rescue cells from cytokine with-
drawal–induced apoptosis. Taken together, these findings
Figure 6. Inhibition of PI3K or direct activation of FKHR-L1 
results in cytochrome c release from mitochondria. Ba/F3 cells 
were IL-3 starved or treated with LY294002, and FKHR-L1(A3):ER 
cells were treated with 4-OHT for the times indicated (in the 
presence of IL-3). Mitochondrial and cytosolic fractions were 
prepared as described in the Materials and methods. Protein 
concentrations were measured, and an equal amount of protein 
from the different fractions was analyzed by SDS-PAGE and 
cytochrome c Western blotting.
Figure 7. Activation of PKB rescues 
cells from apoptosis and maintains 
mitochondrial transmembrane potential. 
(A) Ba/F3 cells stably expressing 
myrPKB:ER* were left untreated or were 
treated with 4-OHT (100 nM) for 36 h. 
PKB phosphorylation was measured 
using a PKB phospho ser-473–specific 
antibody. (B) myrPKB:ER* cells were 
cytokine starved in the absence (left) or 
presence (right) of 4-OHT (100 nM) for 
36 h, and the percentage of annexin
V-FITC–positive cells was determined as 
described in the Materials and methods. 
(C) Ba/F3 cells or Ba/F3 cells stably 
expressing myrPKB:ER* were cytokine 
starved in the absence or presence of 
4-OHT (100 nM) or cultured with IL-3 
for 36 h. Mitochondrial integrity was 
examined using Rh-123 as described in 
the Materials and methods. (D) Caspase-3 
(left) and -7 (right) activation was measured in myrPKB:ER* cells that were cytokine starved for 36 h in the absence or presence of 4-OHT 
(100 nM) using activation-specific antibodies. These cells were then reprobed with RACK1 antibody to verify equal protein loading. All 
data depicted are representative of at least three independent experiments.
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demonstrate that PKB-mediated rescue from apoptosis cor-
relates with mitochondrial potential maintenance and a re-
duction of caspase activity.
 
FKHR-L1 transcriptional activity is important for 
induction of apoptosis after cytokine withdrawal
 
As demonstrated above, induction of FKHR-L1 transcrip-
tional activity recapitulates all known elements of the apop-
totic program normally induced by cytokine withdrawal.
However, the question remains whether FKHR-L1 activity
is also necessary for induction of apoptosis after removal of
survival factors. To attempt to answer this question, we gen-
erated a novel inhibitory mutant of FKHR-L1 (see Materials
and methods). This deletion mutant, FKHRL1-DBD, con-
tains only the DNA-binding domain (DBD) of FKHR-L1,
allowing it to bind DNA but not activate transcription. We
reasoned that ectopic expression of this protein results in
competitive inhibition at the level of FKHR-L1–mediated
transcription. A similar mutant for the related transcription
factor AFX has been previously described (Medema et al.,
2000). It should, however, be noted that although this mu-
tant should inhibit FKHR-L1–induced transcription, it has
the potential to also interfere with both FKHR- and AFX-
mediated transcription as well.
To determine whether FKHRL1-DBD could indeed in-
hibit FKHR-L1–mediated transcription, COS cells were
transiently transfected with the pGL2-p27kip luciferase pro-
moter construct together with a constitutively active FKHR-
L1(A3) mutant and increasing concentrations of the in-
hibitory mutant FKHRL1-DBD. As shown in Fig. 8 A,
FKHR-L1(A3) strongly induced pGL2-p27kip promoter ac-
tivity, which was inhibited by FKHRL1-DBD in a concen-
tration-dependent manner. Similar results were shown for
the pGL2–6xDBE construct, which contains six consecutive
FKHR-L1 binding sites. Again, FKHRL1(A3) strongly in-
duced promoter activity, which was inhibited by increasing
concentrations of FKHRL1-DBD.
Because we have also demonstrated that FKHR-L1 is suf-
ficient to induce p27
 
KIP1
 
 transcription in Ba/F3 cells (Dijk-
ers et al., 2000a), we wished to determine whether inhibi-
tion of FKHR-L1 could reduce p27
 
KIP1
 
 transcription in
response to cytokine withdrawal. Ba/F3 cells were electropo-
rated with the pGL2-p27kip luciferase reporter construct to-
gether with FKHRL1-DBD or a control plasmid. Luciferase
activity was measured in the presence or absence of IL-3,
and the fold induction of promoter activity after cytokine
withdrawal was calculated. As shown in Fig. 8 B, overexpres-
sion of FKHRL1-DBD is indeed able to repress the induc-
tion of p27
 
KIP1
 
 transcription normally associated with cyto-
kine withdrawal in these cells.
To determine then whether inhibition of forkhead-related
transcription factors (FKHR-L1, FKHR, and AFX) could
protect cells from cytokine withdrawal–induced apoptosis,
Ba/F3 cells were transfected with spectrin–green fluores-
cence protein (GFP) plus a control vector, FKHRL1-DBD,
or constitutively active PKB (gagPKB). Cells were cultured
without IL-3 and levels of apoptosis were measured by an-
nexin V binding, as described in the Materials and methods.
Cells transfected with the control vector exhibited the same
Figure 8. Inhibition of FKHR-L1 transcriptional activity protects 
cells from apoptosis induced by cytokine withdrawal. (A) COS 
cells (6-cm wells) were transfected with 50 ng of a renilla luciferase 
construct together with 2 g of the pGL2-p27kip luciferase pro-
moter construct (top) or 2 g of a pGL2–6xDBE luciferase
construct (bottom). Cells were cotransfected either with an empty 
vector (lane 1) with 1, 2, or 4 g of pSG5–mycFKHRL1-DBD 
(lanes 2–4, respectively), or with 2 g pECE-HA-FKHR-L1(A3) 
(lane 5) together with 1, 2, or 4 g of pSG5–mycFKHRL1-
DBD (lanes 6–8, respectively). After 24 h, cells were lysed and 
analyzed for luciferase activity. Data represent the mean of three 
independent experiments  SEM. (B) Ba/F3 cells (107) were 
electroporated with 10 g pGL2-p27kip luciferase promoter 
construct together with 10 g of either a control plasmid (pSG5) 
or pSG5–mycFKHRL1-DBD. After 24 h, cells were lysed and 
analyzed for luciferase activity. Data represent the mean of three 
independent experiments  SD. (C) Ba/F3 cells (107) were 
electroporated with 2 g spectrin–GFP and either 18 g control 
vector (top), FKHRL1-DBD (middle), or gagPKB (bottom). After 
electroporation, dead cells were removed as described in the 
Materials and methods. 48 h later GFP-positive (right panels) 
and GFP-negative (left panels) cells were analyzed by FACS® for 
apoptosis by annexin V–phycoerythrin binding. The percentage 
of annexin V–positive cells is shown. Data depicted are representative 
of at least three independent experiments.
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level of apoptosis as untransfected cells (Fig. 8 C, top).
However, cotransfection of FKHRL1-DBD (Fig. 8 C, mid-
dle) dramatically reduced the level of apoptosis compared
with untransfected cells (17% vs. 36%, respectively). This
rescue from apoptosis was comparable with that observed in
cells transfected with gag-PKB (Fig. 8 C, bottom). Taken
together with our previous findings (Dijkers et al., 2000a,b),
these data demonstrate that FKHR-L1 is indeed an impor-
tant component in regulating the initiation of the apoptotic
program.
 
Inhibition of Bim expression is important for
PI3K-mediated rescue from apoptosis
 
To examine the relevance of inhibition of Bim expression
for PI3K/PKB–mediated rescue from apoptosis in vivo, we
used hematopoietic stem cells isolated from either wild-type
mice or mice lacking both Bim alleles (Bim
 

 
/
 

 
; Bouillet et
al., 1999). Bone marrow Sca1
 
	
 
 stem cells were cultured ei-
ther with cytokines, without cytokines, or with cytokines as
well as the PI3K inhibitor LY294002. Cells were subse-
quently analyzed after 24 h by annexin V staining, or after
48 h by Rh-123 binding (Fig. 9). In cells cultured with cy-
tokines, the level of apoptosis, as measured by annexin V or
Rh-123, is low and exhibits little difference between mice.
Upon removal of survival factors, cells isolated from the
Bim
 

 
/
 

 
 mice have a significantly enhanced survival advan-
tage, demonstrating that Bim is indeed critical in the regula-
tion of hematopoietic stem cell survival. This is particularly
apparent as measured by Rh-123 after 48 h. To determine if
inhibition of Bim levels is a critical component of the mech-
anism by which PI3K/PKB regulates cell survival, stem cells
were treated with LY294002. Treatment of cells isolated
from wild-type mice with this PI3K inhibitor induced apop-
tosis to a level at least equal to that observed upon cytokine
withdrawal (Fig. 9). However, in Bim
 

 
/
 

 
 
 
mice, the percent-
age of apoptotic cells observed after LY294002 treatment
was significantly reduced compared with wild-type, particu-
larly when mitochondrial integrity was analyzed after 48 h
(Fig. 9 B). These data suggest that Bim is a critical down-
stream target of PI3K action.
Taken together, our data indicate that inhibition of
FKHR-L1 activity by PKB-mediated phosphorylation, with
the resultant effect of inhibiting Bim expression, is possibly
one of the critical events by which survival factors prevent
hematopoietic cells from initiating their intrinsic apoptotic
program.
 
Discussion
 
In this report, we analyze the mechanisms of cytokine with-
drawal– and FKHR-L1–induced apoptosis, as well as PKB-
mediated rescue from apoptosis. Using cells expressing
FKHR-L1(A3):ER* allowed us to uniquely analyze the ef-
fects of FKHR-L1 activation. Interestingly, no measurable
differences between cytokine withdrawal– and FKHR-L1–
mediated induction of apoptosis were observed. This sug-
gests that FKHR-L1 alone could account for induction of
the apoptotic program triggered by cytokine withdrawal. In
both cases, cells were first arrested in G
 
1
 
 and subsequently
underwent apoptosis (Fig. 3). This was accompanied by a se-
quential upregulation of p27
 
KIP1
 
, which is involved in arrest-
ing cells in G
 
1
 
 and the induction of apoptosis (Polyak et al.,
1994; Toyoshima and Hunter, 1994; Dijkers et al., 2000a),
and Bim, which can induce apoptosis by binding to anti-
apoptotic members of the Bcl-2 family (O’Connor et al.,
1998) (Fig. 1, B and C). Bim appears to be essential for the
induction of apoptosis in lymphocytes, because cytokine-
deprived lymphocytes from Bim
 

 
/
 

 
 mice fail to undergo
apoptosis (Bouillet et al., 1999). Furthermore, lymphocytes
derived from p27
 
KIP1
 

 
/
 

 
 mice undergo apoptosis at a signifi-
cantly decreased rate compared with those from wild-type
mice (Dijkers et al., 2000a). This suggests that the upregula-
tion of both p27
 
KIP1
 
 and Bim may play critical roles in the
induction of the apoptotic program initiated by cytokine
withdrawal.
We also analyzed whether Fas/FasL signaling may be in-
volved in the induction of apoptosis upon cytokine with-
drawal as previously proposed (Brunet et al., 1999). Neither
cytokine withdrawal nor FKHR-L1 activity resulted in cas-
pase-8 cleavage, an event specific for death receptor signaling
(Juo et al., 1998; Varfolomeev et al., 1998). In addition, cy-
tokine withdrawal had no effect on FasL promoter activity
(Fig. 2 D) or FasL protein expression (unpublished data).
Importantly, treatment of Ba/F3 cells with FasL did not in-
duce apoptosis, suggesting a lack of a functional Fas/FasL
death receptor signaling pathway. This suggests that apopto-
sis induced either by cytokine withdrawal, PI3K inhibition,
or FKHR-L1 activity is initiated through a death receptor–
independent mechanism. In support of this, overexpression
of anti-apoptotic Bcl-2 members, which rescue death recep-
tor–independent apoptosis, but not death receptor–depen-
dent apoptosis in lymphocytes (Itoh et al., 1993; Scaffidi et
al., 1998), are able to rescue both cytokine withdrawal– as
Figure 9. Regulation of Bim expression is critical for PI3K-mediated 
rescue from apoptosis. Hematopoietic stem cells were isolated from 
either wild-type mice or mice lacking both (/) alleles of the BIM 
gene as described in the Materials and methods. Cells were treated 
with cytokines, with or without incubation with 10 M LY294002, 
or were cytokine starved. (A) Annexin V binding was analyzed after 
24 h. (B) The integrity of the mitochondrial transmembrane potential 
was measured by FACS® analysis of Rh-123 binding after 48 h. Data 
represent the mean of four independent experiments  SEM.
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well as FKHR-L1–induced apoptosis (Chao et al., 1998;
Dijkers et al., 2000b). Interestingly, although the FasL pro-
moter was not activated by cytokine withdrawal, a small re-
gion of this promoter previously shown to contain three
forkhead binding sites was (Brunet et al., 1999; Fig. 2 D).
This suggests that in the context of the intact FasL pro-
moter, secondary factors are responsible for mediating pro-
moter activity. Possibly, there are critical forkhead cofactors
absent in Ba/F3 cells, or other factors are expressed that ac-
tively repress FasL promoter activity. This might explain the
differences between our data and that previously described
by Brunet et al. (1999) in T cells.
PKB has been demonstrated to negatively regulate mem-
bers of a subfamily of forkhead transcription factors: AFX,
FKHR, and FKHR-L1 (for review see Datta et al., 1999).
Recently, members of the SGK (serum and glucocorticoid-
induced kinases) family, which phosphorylate consensus se-
quences similar to PKB, were found to be required for full
phosphorylation of FKHR-L1 in vivo and in IL-3–mediated
survival (Liu et al., 2000; Brunet et al., 2001). This suggests
that both kinases may be required for phosphorylation-
mediated inactivation of FKHR-L1, and may explain why
PKB was unable to completely inhibit cytokine withdrawal–
induced apoptosis (Fig. 7). However, PKB was capable of
significantly abrogating cytokine withdrawal–induced loss of
mitochondrial potential (Fig. 7 C). Thus, we can conclude
that PKB exerts its anti-apoptotic effect at a premitochon-
drial level, preventing intracellular release of cytochrome c.
A potential role for PKB in rescue from apoptosis and pre-
vention of cytochrome c leakage has also been proposed in
apoptosis induced in Rat1 fibroblasts by UV irradiation
(Kennedy et al., 1999), as well as in apoptosis induced in ep-
ithelial cells by detachment from the extracellular matrix
(Rytomaa et al., 2000). However, PKB has also been previ-
ously shown to inhibit ceramide-induced apoptosis in hy-
brid neuron motor 1 cells downstream of cytochrome c re-
lease (Zhou et al., 2000). These findings may be explained
by differences in apoptotic stimuli in different cell types, and
indicates that PKB has the potential to act at multiple levels.
Furthermore, difference in species could be an explanation
for the differential contribution of PKB in rescue from
apoptosis. PKB has been suggested to promote rescue from
apoptosis by inhibitory phosphorylation of caspase-9 in hu-
man cells (Cardone et al., 1998), but not in mouse or rat
cells because the PKB phosphorylation site in caspase-9 is
not present (Fujita et al., 1999). PKB has also been linked to
the upregulation of the anti-apoptotic Bcl-2 member Mcl-1
(Wang et al., 1999), which is essential in cytokine-mediated
rescue from apoptosis (Chao et al., 1998). This regulation of
an anti-apoptotic Bcl-2 member, involved in the mainte-
nance of mitochondrial integrity, also supports a role for
PKB upstream of cytochrome c leakage in cytokine-medi-
ated rescue from apoptosis.
The p21ras-activated protein kinase MEK has also been
proposed to rescue cells from apoptosis (Perkins et al., 1996;
Shimamura et al., 2000), potentially through activation of
downstream targets that phosphorylate Bad (Shimamura et
al., 2000). Furthermore, MEK-initiated signals can result in
the phosphorylation of anti-apoptotic members of the Bcl-2
family, thereby enhancing their stability (Breitschopf et al.,
2000). However, using the myrPKB:ER* cell line, we have
demonstrated that PKB alone is sufficient to protect cells
from apoptosis (Fig. 6, B and C). Our data do not, however,
rule out the possibility that MEK plays a role in these events.
Increased PKB activity can result in cellular transforma-
tion (Bellacosa et al., 1991; Cheng et al., 1992; Haas-Kogan
et al., 1998), although the exact mechanisms by which PKB
is capable of promoting oncogenesis remains to be estab-
lished. Inhibitory phosphorylation of FKHR-L1 could very
well contribute to this process, leading to a decrease in both
Bim and p27
 
KIP1
 
 levels. This is supported by the observation
that a decrease in p27
 
KIP1
 
 levels is associated with a poor
prognosis in cancer (Catzavelos et al., 1997; Loda et al.,
1997; Ohtani et al., 1999).
Two critical experiments have demonstrated that FKHR-L1
is a critical effector of cell death induced by cytokine with-
drawal, and that Bim is an important downstream target of
PI3K/PKB action. First, in Fig. 8 we demonstrate that ectopic
expression of an inhibitory FKHR-L1 significantly reduces the
levels of apoptosis observed after cytokine withdrawal. This is
similar to the effect of expressing a constitutively active mutant
of PKB. Although inhibition of apoptosis is dramatic, it is not
complete. This could either be due to additional pro-apoptotic
pathways, or simply that the levels of expression of these trans-
fected proteins is relatively low in Ba/F3 cells. Using Bim
knockout mice, we demonstrate that hematopoietic stem cells
isolated from these animals have much reduced levels of apop-
tosis compared with wild-type mice upon cytokine withdrawal.
This is in agreement with observations previously made in leu-
kocytes isolated from these mice (Bouillet et al., 1999). If inhi-
bition of Bim transcriptional levels is indeed critical for PI3K/
PKB–mediated cell survival, it follows that inhibition of PI3K
activity would have a significantly reduced effect on apoptosis
in cells isolated from Bim-deficient mice. Indeed our data
demonstrate this to be the case (Fig. 9). Thus, it appears that in
cytokine-dependent cells, repression of Bim expression may be
one of the major mechanisms by which PI3K/PKB signaling
results in enhanced cell survival in vivo. It should, however, be
noted that the cytoprotective effects of FKHRL1-DBD and
Bim knockout are not complete. This suggests the possibility
that there are other targets and mechanisms contributing to the
induction of apoptosis upon cytokine withdrawal. Similarly, it
has not been shown that FKHR-L1 is critical for the induction
of Bim upon cytokine withdrawal.
Taken together, our data suggest that cytokine-induced
signaling can inhibit cells from apoptosis through activation
of PKB (or possibly SGK), which inhibits FKHR-L1 and
Bad through phosphorylation and transcriptionally upregu-
lates Mcl-1. In the absence of cytokines, PKB is inactive, re-
sulting in dephosphorylation and activation of Bad and tran-
scription of FKHR-L1 targets p27
 
KIP1
 
 and Bim. This results
in induction of the apoptotic program through loss of mito-
chondrial integrity, leakage of cytochrome c, subsequent ac-
tivation of caspases, and cleavage of substrates. The events
mediating cytokine withdrawal–induced apoptosis, as well
as, cytokine-mediated rescue from apoptosis are summarized
in Fig. 10.
Our findings provide greater insight into the mechanisms
regulating induction of apoptosis in lymphocytes, and prob-
ably other hematopoietic lineages, upon cytokine with-
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drawal. PKB alone is sufficient to inhibit apoptosis through
the maintenance of mitochondrial transmembrane potential.
This is likely due to the inhibition of FKHR-L1, which pre-
vents transcription of the pro-apoptotic Bcl-2 family mem-
ber Bim. A greater understanding of the mechanisms by
which cytokines regulate cellular survival will help toward
the design of novel pharmacological agents for therapeutic
intervention in a variety of proliferative and degenerative
disorders of the immune system.
 
Materials and methods
 
Cell culture
 
Ba/F3 cells were cultured in RPMI 1640 supplemented with 8% Hyclone se-
rum (GIBCO BRL) and recombinant mouse IL-3 produced in COS cells
(Caldenhoven et al., 1995). Monoclonal Ba/F3 cells stably expressing FKHR-
L1(A3):ER* and the polyclonal myrPKB:ER* Ba/F3 cell line have been de-
scribed previously (Dijkers et al., 2000a,b), and were cultured together with
500 
 

 
g/ml G418. For cytokine withdrawal experiments, cells were washed
twice with PBS and resuspended in RPMI 1640 supplemented with 8% Hy-
clone serum and, in the case of the polyclonal myrPKB:ER* Ba/F3 cell line,
cultured for 2 h without cytokines before adding 4-OHT. COS cells were
cultured in DME (GIBCO BRL) supplemented with 8% FCS.
Mice deficient for Bim have been described previously (Bouillet et al.,
1999). Each Bim
 

 
/
 

 
 mouse used in this study was produced by crossing
(C57bl.6J background) and genotyped by PCR analysis. All Bim
 

 
/
 

 
 mice
were compared with age-matched wild-type littermates (3–4 mo old). After
sacrifice, the femurs were removed and bone marrow was flushed out with
Iscove’s modified DuIbecco’s medium (IMDM) containing 20% (vol/vol)
FCS, penicillin, and streptomycin through a MACS prefilter (Miltenyi Bio-
tec). An aliquot was removed, and nucleated cells were counted with an
improved Neubauer chamber after lysing the red cells in 1% (vol/vol) ace-
tic acid. The remaining cells were pelleted and incubated for 15 min at
4
 


 
C with 200 ml Sca1 MultiSort microbeads per 10
 
8
 
 cells. Sca1
 
	
 
 cells
were isolated through two columns, either manually (MACS-MS columns)
or with an AutoMACS machine, according to the manufacturer’s protocol.
The Sca1
 
	
 
 cells were resuspended in Iscove’s modified Dulbecco’s me-
dium (IMDM) containing 20% (vol/vol) FCS, penicillin, and streptomycin
at 10
 
6
 
 cells/ml, and their purity was determined as around 95% by flow cy-
tometry. The Sca1
 
	
 
 cells were isolated for 6–7 d in the presence of IL-3
(10 ng/ml), IL-6 (10 ng/ml), and stem cell factor (100 ng/ml), and fresh me-
dium containing cytokines was added as necessary (Kurata et al., 1998).
 
Antibodies and reagents
 
Polyclonal antibodies against cleaved caspase-3 (#9661), cleaved caspase-7
(#9491S), and PARP (#9542) and phospho-Ser473 PKB (#9271S) were
from New England Biolabs, Inc. Polyclonal caspase-8 antibody (559932)
 
and monoclonal cytochrome c antibody (clone 7H8.2C12) were from BD
PharMingen. Bim polyclonal antibody was purchased from Affinity
BioReagents, Inc. p27
 
KIP1
 
 and RACK1 mAb were purchased from Transduc-
tion Laboratories. PI was from Sigma-Aldrich. The annexin V-FITC kit and
SUPERFas Ligand were from Alexis Biochemicals Corp. Rh-123 was pur-
chased from Molecular Probes. All other chemicals were reagent grade.
pSG5–mycFKHRL1(DBD) was made by PCR cloning nucleotides corre-
sponding to amino acids 141–268 from FKHR-L1(A3) in-frame into pSG5–
myc. FasL promoter and 6
 

 
DBE luciferase reporter constructs were pro-
vided by Anne Brunet (Children’s Hospital, Boston, MA) and Boudewijn
(University Medical Center, Utrecht, Netherlands), respectively.
 
DNA laddering
 
10
 
7
 
 cells were treated as indicated, lysed on ice for 10 min in buffer A (10
mM Tris-Cl, pH 7.4, 10 mM EDTA, 0.2% TX-100, supplemented with 1
mM PMSF, 0.1 mM aprotinin, and 1 mM leupeptin), and centrifuged at
14,000 rpm for 10 min at 4
 


 
C. The supernatant was added to an equal vol-
ume phenol/chloroform, rocked gently for 10 min, centrifuged, and the
upper phase was added to 1/10 vol sodium acetate (3 M, pH 5.4) and 2.5
vol ethanol, incubated at 
 

 
20
 


 
C for 15 min, and subsequently spun down.
The pellet was air dried, resuspended in TE containing 2 
 

 
g/ml RNase A,
incubated at 37
 


 
C for 30 min, and run on a 2% agarose gel.
 
Western blotting
 
For the detection of all proteins, cells were lysed in ELB buffer (50 mM
Hepes, pH 7.4, 150 mM NaCl, 5 mM EDTA together with inhibitors) (Me-
dema et al., 1998). Protein concentration was measured and equal
amounts of protein were analyzed by SDS-PAGE. Blots were incubated
overnight at 4
 


 
C with appropriate antibodies (1:1,000), and after hybridiza-
tion with secondary antibodies, they were developed using ECL (Amer-
sham Pharmacia Biotech).
 
FACS
 
®
 
 analysis of apoptosis
 
Preparation of cells for the analysis of cell cycle profiles has been de-
scribed previously (Dijkers et al., 2000a). For the analysis of apoptosis by
annexin V staining, cells were washed with ice cold PBS and resuspended
in binding buffer (10 mM Hepes, pH 7.4, 140 mM NaCl, 2.5 mM CaCl
 
2
 
).
Cells were then incubated with FITC-conjugated annexin V (Bender Med-
systems) for 10 min at room temperature, washed, and resuspended in
binding buffer containing 1 
 

 
g of PI/ml. Fluorescence was analyzed by
FACS
 
®
 
.
For transient transfections, Ba/F3 cells were electroporated (0.28 kV; ca-
pacitance, 960 
 

 
F), and 2 h after electroporation, dead cells were removed
by separation through a Ficoll gradient (2,500 rpm for 20 min). Cells were
harvested 48 h after electroporation and analyzed by FACS
 
®
 
 as described
above, but using annexin V–phycoerythrin.
 
Analysis of mitochondrial depolarization
 
For the analysis of changes in mitochondrial potential, 
 

 
m
 
 (Ferlini et al.,
1996), cells were incubated in RPMI together with 10 
 

 
g/ml Rh-123 (Mo-
Figure 10. A model for cytokine 
withdrawal–induced apoptosis. In the 
absence of cytokines, PKB and SGK are 
inactive, preventing elevation of the 
anti-apoptotic Bcl-2 member Mcl-1,
and resulting in dephosphorylation and 
subsequent activation of the pro-apoptotic 
Bcl-2 member Bad and the FKHR-L1 
transcription factor. Transcriptional 
activity of FKHR-L1 elevates levels of 
Bim and p27KIP1. p27KIP1 inhibits cell 
cycle progression and helps to promote 
apoptosis in an as yet unidentified 
manner. Bim, possibly together with 
Bad, promotes leakage of cytochrome c 
and subsequent loss of mitochondrial 
integrity. This triggers the activation of 
caspases and subsequent cleavage of 
downstream targets, resulting in apoptosis.
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lecular Probes) at 37
 


 
C for 30 min, washed twice with PBS, and analyzed
by FACS
 
®
 
 (Dijkers et al., 2000b). The percentage of cells falling within the
range of Rh-123 fluorescence, indicative of depolarized cells, is shown.
 
Analysis of intracellular cytochrome c release
from mitochondria
 
Mitochondria and cytosol fractions were obtained using the mitochondria/
cytosol fractionation kit (Kordia) according to the manufacturer’s protocol.
In brief, 5 
 

 
 10
 
7
 
 cells were treated as indicated, washed once in PBS, re-
suspended in 500 
 

 
l cytosol extraction buffer, and incubated on ice for 10
min. Subsequently, cells were homogenized in an ice cold tissue grinder.
The homogenate was centrifuged at 700 
 
g
 
 for 10 min at 4
 


 
C. The remain-
ing supernatant was then centrifuged at 10,000 
 
g
 
 for 30 min at 4
 


 
C. Subse-
quently, the supernatant was collected as the cytosolic fraction. The pellet
was resuspended in 100 
 

 
l mitochondrial extraction buffer and vortexed
for 10 s (mitochondrial fraction). Protein concentration was measured and
equal amounts of protein were analyzed by SDS-PAGE. The amount of cy-
tochrome c in the different fractions was determined by Western blotting
using a monoclonal antibody against cytochrome c.
 
Luciferase assays
 
For transient transfections, Ba/F3 cells were electroporated (0.28 kV; ca-
pacitance, 960 
 

 
F) with 20 
 

 
g of a luciferase reporter plasmid containing
the FasL enhancer region (Holtz-Heppelmann et al., 1998) or a luciferase
reporter containing the portion of the FasL promoter that contains three
forkhead binding sites (FHRE-LUC reporter) (Brunet et al., 1999). Cells
were cotransfected with 50 ng of a renilla luciferase plasmid (pRL-TK;
Promega) to normalize for transfection efficiency. After transfection, cells
were cultured with or without IL-3 for 18 h. Cells were then harvested,
lysed in commercially available luciferase lysis buffer, and luciferase activ-
ity was determined. In some experiments, a luciferase reporter containing
the p27
 
KIP1
 
 promoter was used.
COS cells were transiently transfected with the pGL2-p27kip luciferase
promoter construct or a pGL2–6xDBE luciferase construct (containing six
FKHR-L1 binding sequence), together with pECE-HA-FKHR-L1(A3), pSG5-
myc-FKHRL1-DBD expression, or control vectors and the internal transfec-
tion control (pRL-TK) by calcium phosphate precipitation. Values were
corrected for transfection efficiency and represent the mean of at least
three independent experiments (
 

 
 SEM).
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